{
    "eid": "2-s2.0-84970998458",
    "title": "Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: Comparison with similar data from other populations",
    "cover-date": "2016-06-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        }
    ],
    "keywords": [
        "kidney transplantation",
        "Nonlinear Mixed Effect Model",
        "population pharmacokinetics",
        "tacrolimus",
        "therapeutic drug monitoring"
    ],
    "authors": [
        "S. Vadcharavivad"
    ],
    "citedby-count": 32,
    "ref-count": 37,
    "ref-list": [
        "Annual Report of Kidney Transplant in Thailand",
        "Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the european consensus conference",
        null,
        "Clinical Pharmacokinetics of Tacrolimus",
        "Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation",
        "Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation",
        "The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations",
        "Perl-speaks-NONMEM (PsN) - A Perl module for NONMEM related programming",
        "Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models",
        "Population pharmacokinetics of tacrolimus in adult kidney transplant recipients",
        "Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients",
        "Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients",
        "Tacrolimus population pharmacokinetic-pharmacogenetic analysis and bayesian estimation in renal transplant recipients",
        null,
        "Dosing equation for tacrolimus using genetic variants and clinical factors",
        "A simultaneous D-optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation",
        "Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients",
        "Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: A population pharmacokinetic analysis",
        "Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients",
        "Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation",
        "Total plasma protein effect on tacrolimus elimination in kidney transplant patients - Population pharmacokinetic approach",
        "Importance of hematocrit for a tacrolimus target concentration strategy",
        "Population pharmacokinetics of tacrolimus in adult kidney transplant patients: Impact of CYP3A5 genotype on starting dose",
        "Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling",
        "AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients",
        "Population pharmacokinetics of tacrolimus in kidney transplant patients",
        "Thai Pharm Health Sci J",
        "Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review",
        "Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents",
        "Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease",
        "Pharmacogenetics in solid organ transplantation: Genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs",
        "Genetic polymorphisms of the C\u03a5P3A4, C\u03a5P3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus",
        "The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients",
        "A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients",
        "A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype",
        "Thai J Pharmacol",
        "Population pharmacokinetics and bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Praram 9 Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}